Checklists by Age
Longevity Checklist for Your 50s
CDC vaccine guidance and USPSTF screening criteria for your 50s: why prior doses, smoking history, age and health affect eligibility.
Your 50s add several dates to the prevention calendar. Humanic Blue’s checklist starts with the US Centers for Disease Control and Prevention (CDC) recommendation for two shingles-vaccine doses and its pneumococcal-vaccine guidance, which depends on prior doses. Pneumococcal bacteria can cause pneumonia and other infections. Yearly lung cancer screening applies only to people who meet the US Preventive Services Task Force (USPSTF) age, smoking-history and health criteria. Prostate screening is a decision after discussing benefits and harms: the American Cancer Society suggests that conversation at 50 for men at average risk with a life expectancy of at least 10 years, while the current final USPSTF guidance covers ages 55 to 69. Colorectal, blood-pressure, cholesterol and diabetes screening depend on personal risk and prior results. In a large US cohort, quitting smoking at ages 45 to 54 was associated with about six additional years of life compared with continuing. The CDC recommends muscle-strengthening activity twice weekly; a fracture after 50 or possible sleep-apnea symptoms can prompt a clinical evaluation.
Key Takeaways
- Several age-based steps begin around 50: shingles and pneumococcal vaccination, lung cancer screening for people who meet USPSTF criteria, and an informed prostate-screening conversation. Established (current recommendations).
- In a large US observational cohort, quitting smoking at ages 45 to 54 was associated with about six additional years of life compared with continuing. Supported.
- Mitchell and colleagues found that strength declined two to five times faster than muscle mass in studies measuring both; this does not predict an individual’s rate of loss. Supported.
The checklist at a glance
| Item | What’s new or continuing in your 50s | Source |
|---|---|---|
| Shingles vaccine | 2 doses from 50 | CDC schedule |
| Pneumococcal vaccine | Review from 50 if you have not received a pneumococcal conjugate vaccine | CDC schedule |
| Lung cancer screening | Yearly, ages 50–80, with a 20 pack-year history (current smokers or quit within 15 years) | USPSTF |
| Prostate (men) | Discussion at 50 (ACS, average risk) or individual decision from 55 (USPSTF) | ACS; USPSTF |
| Colorectal | Continue; started at 45 | USPSTF |
| Blood pressure, cholesterol and other blood fats, diabetes | Screening interval and risk review depend on history and results | USPSTF; American College of Cardiology/American Heart Association; American Diabetes Association |
| Smoking | Quitting at 45–54 was associated with about 6 more years than continuing | Jha et al., NEJM |
| Strength | Muscle-strengthening activity on at least 2 days weekly | CDC |
| Bone | A recent fracture after 50 warrants evaluation for osteoporosis, in which bones become fragile | Bone Health and Osteoporosis Foundation |
| Sleep apnea | Mention loud snoring, witnessed breathing pauses or daytime sleepiness | Clinical evaluation; Peppard et al. |
| Menopause (women) | Bone and body-composition changes accelerate around the final menstrual period | Study of Women’s Health Across the Nation (SWAN) |
Which screenings change in your 50s?
Lung cancer, if you smoked. The current final USPSTF recommendation calls for yearly screening with low-dose computed tomography (CT), an X-ray scan, for adults ages 50 to 80 with at least a 20 pack-year smoking history (packs smoked per day multiplied by years; one pack daily for 20 years is 20 pack-years) who currently smoke or quit within the past 15 years. Screening stops once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.
Prostate (men). The American Cancer Society advises an informed discussion at 50 for men at average risk who are expected to live at least 10 more years; it recommends earlier discussions for higher-risk groups. The current final USPSTF recommendation makes prostate-specific antigen (PSA) blood testing an individual screening decision from ages 55 to 69 after discussing possible benefit and harms, and it is being updated. Both are covered in Healthy Aging for Men in Their 50s.
The continuing list. Colorectal screening, blood-pressure screening, lipid and cardiovascular-risk review, and diabetes screening all continue in the 50s. The schedule and test choice depend on prior results and risk; the overview is in Longevity Checklist for Your 40s.
How do smoking history, fracture risk and screening harms shape different decisions in the 50s?
Vaccinate
The CDC recommends two doses of recombinant shingles vaccine, usually two to six months apart, for adults age 50 and older. The current compliant adult immunization schedule also recommends pneumococcal vaccination beginning at 50 for adults who have not received a pneumococcal conjugate vaccine, with the product and follow-up depending on vaccination history and health conditions. A pharmacist or clinician can review the live schedule with you.
Smoking, fractures and sleep symptoms
Smoking. In a 2013 prospective cohort study linking survey data from about 200,000 US adults to death records, adults who quit at ages 45 to 54 lived about six years longer than those who continued. This was an observational estimate, not a randomized test of quitting.
Bone. The Bone Health and Osteoporosis Foundation clinician’s guide advises investigating any broken bone in adulthood as suspicious for osteoporosis and notes that a recent fracture in an adult age 50 or older raises the risk of another fracture, especially during the following one to two years. That does not mean every fracture proves osteoporosis; it means the event deserves evaluation. The distinction is covered in Osteoporosis vs. Osteopenia.
Sleep apnea. Sleep apnea involves repeated pauses in breathing during sleep. A 2013 Wisconsin Sleep Cohort analysis used repeated overnight sleep studies and statistical weighting to estimate moderate-to-severe sleep-disordered breathing in 17% of men and 9% of women ages 50 to 70. These were modeled population estimates from a predominantly White working cohort, not a diagnosis rate for every group. Symptoms such as loud snoring, witnessed breathing pauses or persistent daytime sleepiness are reasons to discuss evaluation with a clinician.
What happens to muscle and bone in your 50s?
Strength. A 2012 quantitative review found that studies measuring both outcomes in the same people reported strength declining two to five times faster than muscle mass. The reviewed studies used varied populations and methods, so the figure is a range rather than a personal forecast. The CDC recommends muscle-strengthening activity on at least two days each week; training evidence is covered in Prevent Muscle Loss After 50.
Fitness. In a two-year randomized trial of about 60 healthy, sedentary adults averaging 53 years old, the structured exercise group increased VO2 max—a measure of how much oxygen the body can use during intense exercise—by 18%. The comparison group did not follow the same structured exercise program and did not improve that measure. It was a small, single-center trial and did not test lifespan. The program is covered in Improve VO2 Max After 40.
Menopause. Analyses from the Study of Women’s Health Across the Nation (SWAN), which followed participants over time, found that bone loss accelerated around the final menstrual period and that lean mass (body tissue other than fat) began declining at the start of the menopause transition, with the latter trend continuing until about two years after the final period. These are average changes observed over time, not predictions for every woman. The evidence is covered in Protect Bone Health During Menopause and Protect Muscle During Menopause.
What would a checklist miss if it tracked muscle mass without tracking strength?
What’s Interesting
The 50s checklist mixes finite tasks with recurring decisions. The shingles series is two doses, while lung screening—when a person qualifies—is annual and PSA screening depends partly on how someone weighs the possible benefits and harms, and that decision may be revisited. Alongside them sit long-running priorities such as strength, fitness and smoking cessation.
What This Means in Practice
- Shingles vaccination: the CDC recommends a two-dose series from 50; a clinician or pharmacist can check prior doses and your circumstances.
- Lung screening: the USPSTF’s yearly low-dose CT recommendation applies only when its age, pack-year, quit-date and health criteria are met; a clinician can review your smoking history.
- Prostate screening: the ACS and USPSTF call for a discussion of benefits and harms within their respective age and risk groups, rather than an automatic PSA test.
- Continuing checks: colorectal, blood-pressure, lipid and diabetes screening intervals depend on prior results and individual risk; a clinician can review the record.
- Activity: the CDC recommends muscle-strengthening on at least two days weekly alongside aerobic activity; the type and intensity can be adjusted to health and ability.
- Bone and sleep symptoms: a recent fracture, witnessed breathing pauses or persistent daytime sleepiness are reasons to discuss evaluation with a clinician.
A primary care clinician can cover this list. A pharmacist can handle vaccines.
Bottom Line
For living longer and better in the 50s, the named US authorities add shingles and pneumococcal vaccination, lung cancer screening for people who meet the USPSTF criteria and an informed prostate-screening conversation to the heart, blood-sugar and colorectal checks already under way. An observational cohort estimated about six additional years of life for people who quit smoking at ages 45 to 54 rather than continuing. Strength and fitness remain trainable, a fracture after 50 deserves a bone-health review, and possible sleep-apnea symptoms deserve evaluation. How much any single item changes an individual’s lifespan is unknown; living longer is a different outcome from improving fitness, preventing infection or detecting disease.
A NOTE FROM LONGEVITY365
We read research, consult expert perspectives and work to make complicated health information easier to understand. What you’re reading here reflects how we’ve interpreted and organized that information. It is educational content—not personal medical advice, diagnosis or treatment guidance.
We’re not perfect, and neither is the available research. Evidence changes, new studies emerge and what’s appropriate for one person may not be appropriate for another.
Use this article as a starting point for your own research and conversations with qualified professionals. Always talk with your doctor or another trusted healthcare professional before making decisions that could affect your health, particularly if you take medications, are receiving treatment, have existing health conditions, are pregnant or have other circumstances that could affect what’s appropriate for you.
Reader Questions
A few questions to carry into the comments or your next conversation. Please leave out identifying or personal medical details.
- 01Which part of this guide feels easiest to turn into a better question for a routine visit?
- 02Where do you still feel the line is blurry between a useful check and more testing than you need?
- 03What would make the next conversation clearer: timing, eligibility, possible harms, or what happens after an abnormal result?
Extra Insights & Sources
The evidence summaries and linked sources behind this article.
What We Know
- Shingles and pneumococcal vaccination, lung cancer screening for eligible smokers and prostate-screening discussions begin around 50 under current US recommendations. Established (recommendations).
- Quitting smoking at ages 45 to 54 was associated with about six additional years of life compared with continuing in a large US cohort. Supported (observational).
- Strength training still builds muscle after 50. Supported.
What We Don’t Know
- How much any single item adds to an individual’s lifespan. Unknown.
- The best prostate-screening approach. The USPSTF is updating its guidance. Contested.
Sources
- USPSTF, Lung Cancer: Screening (2021). Current final recommendation supporting annual low-dose CT from ages 50–80 for people with at least a 20 pack-year history who currently smoke or quit within 15 years, plus the stopping criteria stated in the story. Eligibility does not mean screening is harmless. Tradeoffs include false alarms, unrelated findings that may lead to more testing, radiation and follow-up procedures that enter the body. Recommendation
- American Cancer Society, Prostate Cancer Early Detection, and USPSTF, Prostate Cancer: Screening (2018). ACS supports an informed discussion at 50 for average-risk men expected to live at least 10 more years and earlier for higher-risk groups. The current final USPSTF recommendation supports individual decision-making from ages 55–69 after discussing small potential benefit and harms; its update is in progress. ACS guidance; USPSTF recommendation
- USPSTF, Colorectal Cancer: Screening (2021). Current final recommendation supporting screening from ages 45–75, with several test options and intervals; ages 76–85 require selective individual decisions. The article uses it only to establish that screening continues through the 50s. Recommendation
- USPSTF blood-pressure and diabetes recommendations; ADA Standards of Care—2026; ACC/AHA dyslipidemia guideline—2026. Current guidance supporting continued blood-pressure screening, diabetes testing and lipid/cardiovascular-risk review in the 50s. Exact timing and treatment depend on risk and results; these recommendations do not establish a personal lifespan gain. Blood pressure; USPSTF diabetes; ADA 2026; ACC/AHA 2026
- CDC, Shingles Vaccination (reviewed August 19, 2025), and current compliant adult immunization schedule (accessed September 29, 2026). Supports two-dose recombinant zoster vaccination from age 50 and review of pneumococcal vaccination from age 50 based on prior doses and health conditions. Vaccine schedules can change; the live schedule governs. Shingles guidance; adult schedule
- Jha P, et al., New England Journal of Medicine (2013), PMID 23343063. Prospective US cohort linking National Health Interview Survey data from 113,752 women and 88,496 men to death records. Supports the estimate of roughly six additional years of life among people who quit at ages 45–54 compared with those who continued smoking. Because the study observed people rather than assigning them to quit or continue, other differences between groups may still affect the result. PubMed record
- LeBoff MS, et al., Bone Health and Osteoporosis Foundation clinician’s guide (2022), PMID 35478046. Clinical guide supporting evaluation of adult fractures as suspicious for osteoporosis and the heightened near-term risk after a recent fracture in adults age 50 or older. It is professional guidance; individual trauma circumstances and bone-health findings still matter. Several committee authors disclosed industry relationships. Open full text
- Peppard PE, et al., American Journal of Epidemiology (2013), PMID 23589584. Wisconsin Sleep Cohort analysis using repeated overnight polysomnography (a sleep study recording breathing and other body signals) and statistical weighting to estimate moderate-to-severe sleep-disordered breathing in 17% of men and 9% of women ages 50–70. These are modeled estimates from a predominantly White employed cohort and may not generalize to every population. PubMed record
- Mitchell WK, et al., Frontiers in Physiology (2012), PMID 22934016. Review combining numbers from varied human studies, some comparing different people at one time and others following the same people over time. Supports the reported range that strength declined two to five times faster than muscle mass in studies measuring both in the same samples. It does not predict an individual’s rate of loss. PubMed record
- CDC, Physical Activity Guidelines for Adults (reviewed 2025). Supports at least two days of muscle-strengthening activity weekly, alongside aerobic activity. This is a population target, not an individualized exercise prescription. Guidance
- Howden EJ, et al., Circulation (2018), PMID 29311053. Two-year randomized trial of 61 healthy sedentary middle-aged adults (mean age 53; 53 completers). VO2 max increased 18% in the structured-exercise group and did not improve in the attention-control group. Small, single-center study; it measured fitness and cardiac stiffness, not mortality or lifespan. PubMed record
- Greendale GA, et al., SWAN analyses (2012 and 2019), PMIDs 21976317 and 30843880. Longitudinal human cohort evidence supporting accelerated bone loss around the final menstrual period and declining lean mass from the start of the menopause transition until roughly two years afterward. The 2012 bone analysis included 862 women from four racial and ethnic groups over a 10-year window; the 2019 body-composition analysis drew repeated dual-energy X-ray absorptiometry (DXA) measurements of body composition from the multisite SWAN cohort. Observational averages do not predict every woman. Bone analysis; body-composition analysis
Photo credits
Images from Pexels.
- featured: Photo by Tima Miroshnichenko — original Pexels photo.
- inline-1: Photo by Kampus Production — original Pexels photo.
- inline-2: Photo by Sogi . — original Pexels photo.
Leave a Reply